Tumor Board Review, Second Edition
Guideline and Case Reviews in Oncology
Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Reference, Test Preparation & Review
| Author: | ISBN: | 9781617052231 | |
| Publisher: | Springer Publishing Company | Publication: | February 12, 2015 |
| Imprint: | Demos Medical | Language: | English |
| Author: | |
| ISBN: | 9781617052231 |
| Publisher: | Springer Publishing Company |
| Publication: | February 12, 2015 |
| Imprint: | Demos Medical |
| Language: | English |
Praise for the First Edition
“As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information…by the time the book is [published]…it is outdated.” [Tumor Board Review] is fresh and just out of the oven…I haven’t seen any book in oncology like this so far…I think my investment in this book was wise and worth it.” — Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center
Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists — both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam.
The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several “tumor board style” illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process.
NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW:
- Presents the most recent guidelines and management standards in user-friendly format
- Focuses on current indications, use of new drugs, and new treatment of side effects
- Includes new FDA-approved drugs and guidelines
- Offers approximately 250 multiple-choice questions and answers
Praise for the First Edition
“As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information…by the time the book is [published]…it is outdated.” [Tumor Board Review] is fresh and just out of the oven…I haven’t seen any book in oncology like this so far…I think my investment in this book was wise and worth it.” — Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center
Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists — both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam.
The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several “tumor board style” illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process.
NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW:
- Presents the most recent guidelines and management standards in user-friendly format
- Focuses on current indications, use of new drugs, and new treatment of side effects
- Includes new FDA-approved drugs and guidelines
- Offers approximately 250 multiple-choice questions and answers
